Evidence map›Paper›PMID 40330580›Full record

ArticleIDCases2025

A case of recurrent

Divya Chandramohan, Samantha Aguilar, Gerard Gawrys, Nathan P Wiederhold, Kristi Traugott, Thomas F Patterson

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Rezafungin for the treatment of invasive candidiasis secondary to esophagogastric anastomotic leak: clinical success in a complex situation.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Article
  3. Article
  4. A Review of Current Insights in Fungal Endocarditis.Journal of clinical medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Divya ChandramohanDivision of Infectious Diseases, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, United States.
Samantha AguilarDepartment of Pharmacotherapy and Pharmacy Services, University of Texas Health, San Antonio, 4502 Medical Drive, San Antonio, TX 78229, United States.
Gerard GawrysDepartment of Pharmacotherapy and Pharmacy Services, University of Texas Health, San Antonio, 4502 Medical Drive, San Antonio, TX 78229, United States.
Nathan P WiederholdDepartments of Pathology & Laboratory Medicine, Director, Fungus Testing Laboratory, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, United States.
Kristi TraugottDepartment of Pharmacotherapy and Pharmacy Services, University of Texas Health, San Antonio, 4502 Medical Drive, San Antonio, TX 78229, United States.
Thomas F PattersonDivision of Infectious Diseases, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antifungal resistance in

Indexed as

Candida glabrataCongenital heart disease infectionsEchinocandinEndocarditisRecurrent CandidiasisResistance mechanismsRezafungin

Identifiers

PMID40330580
PMCPMC12051642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.